RVMD: Sandler Alan B. discloses securities transactions
By AlphaYouPublished Form 4
Sandler Alan B.
Reporting filer
Sandler Alan B. reported Exercise or conversion in Revolution Medicines, Inc.: 6000 units of Common Stock, dated 2026-09-29. The full Form 4 contains 7 transaction entries.
- Disclosed
- Oct 1, 2026
Reported details
7 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sandler Alan B. | 2026-09-29 | M | Exercise or conversion | 6000 | 58.84 | 58,868 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-29 | S | Sale | 2200 | 200.8188 | 56,668 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-29 | S | Sale | 1609 | 201.7239 | 55,059 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-29 | S | Sale | 1000 | 202.8127 | 54,059 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-29 | S | Sale | 1199 | 203.9074 | 52,860 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-29 | S | Sale | 301 | 204.7224 | 52,559 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Sandler Alan B. | 2026-09-29 | M | Exercise or conversion | 6000 | 0 | 161,300 | 2 days | Filed terms
|
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 6000
- Price
- 58.84
- Following holdings
- 58,868
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- id: F1
- transaction Shares: 6000
- transaction Price Per Share: 58.84
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 58868
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 2200
- Price
- 200.8188
- Following holdings
- 56,668
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 2200
- transaction Price Per Share: 200.8188
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 56668
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 1609
- Price
- 201.7239
- Following holdings
- 55,059
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1609
- transaction Price Per Share: 201.7239
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 55059
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 1000
- Price
- 202.8127
- Following holdings
- 54,059
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1000
- transaction Price Per Share: 202.8127
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 54059
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 1199
- Price
- 203.9074
- Following holdings
- 52,860
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1199
- transaction Price Per Share: 203.9074
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 52860
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- S
- Action
- Sale
- Quantity
- 301
- Price
- 204.7224
- Following holdings
- 52,559
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 301
- transaction Price Per Share: 204.7224
- id: F6
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 52559
- id: F7
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Sandler Alan B.
- Date
- 2026-09-29
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 6000
- Price
- 0
- Following holdings
- 161,300
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 58.84
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- id: F1
- transaction Shares: 6000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F8
- expiration Date: 2035-11-01
- underlying Security Title: Common Stock
- underlying Security Shares: 167300
- shares Owned Following Transaction: 161300
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sandler Alan B.: Chief Development Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
- F2: The transaction was executed in multiple trades at prices ranging from $200.41 to $201.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3: The transaction was executed in multiple trades at prices ranging from $201.41 to $202.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F4: The transaction was executed in multiple trades at prices ranging from $202.42 to $203.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5: The transaction was executed in multiple trades at prices ranging from $203.42 to $204.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F6: The transaction was executed in multiple trades at prices ranging from $204.43 to $204.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F7: Includes 52,350 restricted stock units.
- F8: Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from September 29, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.